申请人:Genetics Institute LLC
公开号:US06630496B1
公开(公告)日:2003-10-07
This invention provides substituted indole and indoline compounds useful in inhibiting phospholipase activity, particularly including cytosolic phospholipase A2 (cPLA2) activity, as well as pharmaceutical compositions containing the compounds and methods of using them to treat various maladies, including pain and inflammatory conditions.
这项发明提供了替代吲哚和吲哚啉化合物,可用于抑制磷脂酶活性,特别是包括细胞质磷脂酶A2(cPLA2)活性,以及含有这些化合物的药物组合物和使用它们治疗各种疾病的方法,包括疼痛和炎症症状。